<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32397909</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.</ArticleTitle><Pagination><StartPage>1194</StartPage><EndPage>1205</EndPage><MedlinePgn>1194-1205</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2020.1767512</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71), a positive-stranded RNA virus of the Picornaviridae family, may cause neurological complications or fatality in children. We examined specific factors responsible for this virulence using a chemical genetics approach. Known compounds from an anti-EV-A71 herbal medicine, <i>Salvia miltiorrhiza</i> (Danshen), were screened for anti-EV-A71. We identified a natural product, rosmarinic acid (RA), as a potential inhibitor of EV-A71 by cell-based antiviral assay and <i>in vivo</i> mouse model. Results also show that RA may affect the early stage of viral infection and may target viral particles directly, thereby interfering with virus-P-selectin glycoprotein ligand-1 (PSGL1) and virus-heparan sulfate interactions without abolishing the interaction between the virus and scavenger receptor B2 (SCARB2). Sequencing of the plaque-purified RA-resistant viruses revealed a N104K mutation in the five-fold axis of the structural protein VP1, which contains positively charged amino acids reportedly associated with virus-PSGL1 and virus-heparan sulfate interactions via electrostatic attraction. The plasmid-derived recombinant virus harbouring this mutation was confirmed to be refractory to RA inhibition. Receptor pull-down showed that this non-positively charged VP1-N104 is critical for virus binding to heparan sulfate. As the VP1-N104 residue is conserved among different EV-A71 strains, RA may be useful for inhibiting EV-A71 infection, even for emergent virus variants. Our study provides insight into the molecular mechanism of virus-host interactions and identifies a promising new class of inhibitors based on its antiviral activity and broad spectrum effects against a range of EV-A71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chung-Fan</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jheng</LastName><ForeName>Jia-Rong</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Guan-Hua</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yu-Li</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jin-Yuan</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chien-Jou</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Kuei-Yang</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuan-Siao</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yoke Fun</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Hui-Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Pei-Wen</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Industry of Human Ecology and Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chern</LastName><ForeName>Jyh-Haur</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horng</LastName><ForeName>Jim-Tong</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections and Healthy Aging Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002934">Cinnamates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053630">Depsides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084882">P-selectin ligand protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002934" MajorTopicYN="N">Cinnamates</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053630" MajorTopicYN="N">Depsides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027561" MajorTopicYN="N">Salvia miltiorrhiza</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055672" MajorTopicYN="N">Static Electricity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000097123" MajorTopicYN="N">Rosmarinic Acid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus A71</Keyword><Keyword MajorTopicYN="N">P-selectin glycoprotein ligand-1</Keyword><Keyword MajorTopicYN="N">five-fold axis</Keyword><Keyword MajorTopicYN="N">heparan sulfate</Keyword><Keyword MajorTopicYN="N">receptor</Keyword><Keyword MajorTopicYN="N">rosmarinic acid</Keyword><Keyword MajorTopicYN="N">scavenger receptor B2</Keyword><Keyword MajorTopicYN="N">viral entry</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32397909</ArticleId><ArticleId IdType="pmc">PMC7448925</ArticleId><ArticleId IdType="doi">10.1080/22221751.2020.1767512</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. . Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Wang X, Wang Q, et al. . Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5(9):692&#x2013;703. doi: 10.1007/s13238-014-0087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng W, Ren J, et al. . A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19(4):424&#x2013;429. doi: 10.1038/nsmb.2255</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY, et al. . Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9(1):78&#x2013;85. doi: 10.3201/eid1301.020112</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1301.020112</ArticleId><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Chikahira M, Yoshida S, et al. . Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002;46(9):621&#x2013;627. doi: 10.1111/j.1348-0421.2002.tb02743.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02743.x</ArticleId><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, et al. . An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341(13):929&#x2013;935. doi: 10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tu P, Thao NTT, Perera D, et al. . Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13(11):1733&#x2013;1741. doi: 10.3201/eid1311.070632</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1311.070632</ArticleId><ArticleId IdType="pmc">PMC3375788</ArticleId><ArticleId IdType="pubmed">18217559</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan XJ, Wang HY, et al. . An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009;44(4):262&#x2013;267. doi: 10.1016/j.jcv.2009.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence-Davizon E, Osborne C, et al. . Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis. 2020;20(2):230&#x2013;239. doi: 10.1016/S1473-3099(19)30632-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S.. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27(1):23. doi: 10.1186/s12929-020-0615-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, et al. . Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87(6):3335&#x2013;3347. doi: 10.1128/JVI.02070-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, et al. . Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A. 2013;110(14):5463&#x2013;5467. doi: 10.1073/pnas.1222379110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chern JH, Chang CS, Tai CL, et al. . Synthesis and antipicornavirus activity of (R)- and (S)-1-[5-(4&#x2032;-chlorobiphenyl-4-yloxy)-3-methylpentyl]-3-pyridin-4-yl-imidazolidin- 2-one. Bioorg Med Chem Lett. 2005;15(19):4206&#x2013;4211. doi: 10.1016/j.bmcl.2005.06.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2005.06.069</ArticleId><ArticleId IdType="pubmed">16054357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho JY, Chern JH, Hsieh CF, et al. . In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71. J Antimicrob Chemother. 2016;71(7):1922&#x2013;1932. doi: 10.1093/jac/dkw101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkw101</ArticleId><ArticleId IdType="pubmed">27098012</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, et al. . Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;797. doi: 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V, Tseligka ED, Jones ST, et al. . Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses. 2019;11(7):596. doi: 10.3390/v11070596</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070596</ArticleId><ArticleId IdType="pmc">PMC6669472</ArticleId><ArticleId IdType="pubmed">31266258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, et al. . VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79&#x2013;87. doi: 10.1016/j.virol.2016.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, McLaughlin NP, Pan J, et al. . The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog. 2015;11(10):e1005184. doi: 10.1371/journal.ppat.1005184</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005184</ArticleId><ArticleId IdType="pmc">PMC4592248</ArticleId><ArticleId IdType="pubmed">26430888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Lee H, Thibaut HJ, et al. . Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. PLoS Pathog. 2019;15(5):e1007760. doi: 10.1371/journal.ppat.1007760</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007760</ArticleId><ArticleId IdType="pmc">PMC6590834</ArticleId><ArticleId IdType="pubmed">31071193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W, McDonald SP, Hawley CM, et al. . Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease [Multicenter StudyResearch Support, Non-U.S. Gov't]. Kidney Int. 2013;83(3):503&#x2013;510. doi: 10.1038/ki.2012.375</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2012.375</ArticleId><ArticleId IdType="pubmed">23254902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, et al. . Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9(7):e1003511. doi: 10.1371/journal.ppat.1003511</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu BW, Pan TL, Leu YL, et al. . Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med (Gard City N Y). 2007;35(1):153&#x2013;168. doi: 10.1142/S0192415X07004709</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X07004709</ArticleId><ArticleId IdType="pubmed">17265559</ArticleId></ArticleIdList></Reference><Reference><Citation>Astani A, Reichling J, Schnitzler P.. Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy. 2012;58(1):70&#x2013;77. doi: 10.1159/000335590</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000335590</ArticleId><ArticleId IdType="pubmed">22377592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Lee HK, Shin CG, et al. . HIV integrase inhibitory activity of Agastache rugosa. Arch Pharm Res. 1999 Oct;22(5):520&#x2013;523. doi: 10.1007/BF02979163</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02979163</ArticleId><ArticleId IdType="pubmed">10549582</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M, Simmonds MS.. Rosmarinic acid. Phytochemistry. 2003;62(2):121&#x2013;125. doi: 10.1016/S0031-9422(02)00513-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9422(02)00513-7</ArticleId><ArticleId IdType="pubmed">12482446</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Ghosh J, Ghosh S, et al. . Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007;51(9):3367&#x2013;3370. doi: 10.1128/AAC.00041-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00041-07</ArticleId><ArticleId IdType="pmc">PMC2043228</ArticleId><ArticleId IdType="pubmed">17576830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WY, Yu YJ, Jinn TR.. Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study. Virol J. 2019;16(1):94. doi: 10.1186/s12985-019-1203-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-019-1203-z</ArticleId><ArticleId IdType="pmc">PMC6670152</ArticleId><ArticleId IdType="pubmed">31366366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, et al. . A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WF, Yang SY, Wu BW, et al. . Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 2007;282(8):5888&#x2013;5898. doi: 10.1074/jbc.M611145200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611145200</ArticleId><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CW, Leu YL, Horng JT.. Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses. 2012;4(4):539&#x2013;556. doi: 10.3390/v4040539</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4040539</ArticleId><ArticleId IdType="pmc">PMC3347322</ArticleId><ArticleId IdType="pubmed">22590685</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Au JL, Wientjes MG.. Comparison of methods for evaluating drug-drug interaction [Comparative Study Research Support, N.I.H., Extramural]. Front Biosci (Elite Ed). 2010;2:241&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885905</ArticleId><ArticleId IdType="pubmed">20036874</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Zhao Y, Kotecha A, et al. . Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat Microbiol. 2019;4(3):414&#x2013;419. doi: 10.1038/s41564-018-0319-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechecchi MC, Tamanini A, Bonizzato A, et al. . Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology. 2000;268(2):382&#x2013;390. doi: 10.1006/viro.1999.0171</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.0171</ArticleId><ArticleId IdType="pubmed">10704346</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, et al. . Bypassing pan-enterovirus host factor PLA2G16. Nat Commun. 2019;10(1):3171. doi: 10.1038/s41467-019-11256-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Vachino G, Chang XJ, Veldman GM, et al. . P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem. 1995;270(37):21966&#x2013;21974. doi: 10.1074/jbc.270.37.21966</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.37.21966</ArticleId><ArticleId IdType="pubmed">7545173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Lin HY, Tsou YL, et al. . Human SCARB2-mediated entry and endocytosis of EV71. PloS One. 2012;7(1):e30507. doi: 10.1371/journal.pone.0030507</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CC, Lau SK, Lo JY, et al. . Genetic characterization of EV71 isolates from 2004 to 2010 reveals predominance and persistent circulation of the newly proposed genotype D and recent emergence of a distinct lineage of subgenotype C2 in Hong Kong. Virol J. 2013;10:222. doi: 10.1186/1743-422X-10-222</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-222</ArticleId><ArticleId IdType="pmc">PMC3716818</ArticleId><ArticleId IdType="pubmed">23822185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>